New drug ITI-333 tested in healthy people for safety
NCT ID NCT05732194
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This early-stage study tested the safety and how the body handles a new drug called ITI-333. It involved 32 healthy adults aged 18 to 45 who took either the drug or a placebo daily for 14 days. The goal was to check for side effects and measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Site 1
Miami, Florida, 33014-3616, United States
Conditions
Explore the condition pages connected to this study.